Mazen Animal Health operates in the animal health market, leveraging biotechnology to develop plant-based vaccines that are administered orally via animal feed. The company's innovative approach replaces traditional injectable vaccines, aiming to lower production costs, improve worker safety, enhance animal welfare, and strengthen biosecurity. Mazen's core clients include livestock producers and animal health professionals who benefit from more efficient and safer vaccination methods. The business model focuses on the production and sale of these plant-based vaccines, generating revenue through direct sales and partnerships within the animal health industry. By utilizing molecular farming technologies, Mazen transforms plants into natural production factories for recombinant proteins and other high-value molecules, positioning itself at the forefront of this emerging field. The company is committed to continuous improvement and long-term partnerships within the animal health community, driven by a diverse team with expertise in biotechnology, production, manufacturing, and business acumen.

Keywords: plant-based vaccines, oral delivery, animal health, biotechnology, molecular farming, recombinant proteins, livestock, biosecurity, cost reduction, animal welfare.